Paul Colavita, MD
Surgery · Charlotte, NCNPI 1053546861
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,615 of the $5,583 with a category attached, or 82.7%. 12 manufacturers reported payments, led by TELA Bio, Inc. at 24.2% of the total. 2025 is the largest year on record at $1,613, 2.4 times the $686 reported in 2019.
Across 82 payments — averaging $68.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$1K
- RTI Surgical, Inc$786
- AbbVie$738
- Johnson & Johnson$646
- Intuitive Surgical$586
- Olympus America Inc.$504
- plus $974 from 6 others
Across 4 payments — averaging $13,953 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Covidien LP$51K
- Medtronic$5K
What the payments were for
- Travel & lodging$96817%
- Food & beverage$4,61583%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 11 | $1,349 |
| RTI Surgical, Inc | 5 | $786 |
| AbbVie | 7 | $738 |
| Johnson & Johnson | 22 | $646 |
| Intuitive Surgical | 11 | $586 |
| Olympus America Inc. | 18 | $504 |
| Davol Inc. | 2 | $253 |
| Enterra Medical, Inc. | 2 | $219 |
| CSA Medical, Inc | 1 | $198 |
| Innovation Technologies Inc | 1 | $163 |
| Boston Scientific | 1 | $118 |
| Medtronic | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,583 in reported general payments places this provider in the 65th percentile of 970 surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 66 | $1,103 |
| Rabeprazole Sodium | 17 | $760 |
| Famotidine | 42 | $530 |
| Esomeprazole Magnesium | 14 | $318 |
| Pantoprazole Sodium | 27 | $296 |
| Buspirone Hcl | 11 | $104 |
| Oxycodone Hcl | 23 | $89 |
| Ondansetron Hcl | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Other surgery in Charlotte
- Brant HenifordCharlotte$831K
- Vedra AugensteinCharlotte$789K
- John MartinieCharlotte$712K
- David IannittiCharlotte$360K
- Gregory StanleyCharlotte$304K
- Erin BakerCharlotte$221K
- John GreenCharlotte$202K
- Bradley ThomasCharlotte$162K
- Keith GersinCharlotte$80K
- Timothy KuwadaCharlotte$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.